An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.

MLA

Good, Phillip D., et al. “An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.” Journal of Palliative Medicine, vol. 23, no. 5, May 2020, pp. 650–55. EBSCOhost, https://doi.org/10.1089/jpm.2019.0540.

APA

Good, P. D., Greer, R. M., Huggett, G. E., & Hardy, J. R. (2020). An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care. Journal of Palliative Medicine, 23(5), 650–655. https://doi.org/10.1089/jpm.2019.0540

Chicago

Good, Phillip D, Ristan M Greer, Georgina E Huggett, and Janet R Hardy. 2020. “An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.” Journal of Palliative Medicine 23 (5): 650–55. doi:10.1089/jpm.2019.0540.